Net Cash Provided by (Used in) Operating Activities |
-412K |
USD |
+25.6% |
Q1 2022 |
Q1 2022 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2022 |
Q3 2022 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-412K |
USD |
-142% |
Q1 2022 |
Q1 2022 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
96.9K |
USD |
-88.6% |
Q3 2022 |
Q3 2022 |
Deferred Tax Assets, Valuation Allowance |
632K |
USD |
|
Q3 2022 |
Q3 2022 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
|
Q3 2022 |
Q3 2022 |
Deferred Tax Assets, Gross |
632K |
USD |
|
Q3 2022 |
Q3 2022 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2022 |
Q3 2022 |
Deferred Federal Income Tax Expense (Benefit) |
-49.8K |
USD |
|
Q3 2022 |
Q3 2022 |
Preferred Stock, Shares Authorized |
1M |
shares |
0% |
Q3 2022 |
Q3 2022 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q3 2022 |
Q3 2022 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2022 |
Q3 2022 |
Current Federal Tax Expense (Benefit) |
190K |
USD |
|
Q3 2022 |
Q3 2022 |
Share-based Payment Arrangement, Expense |
0 |
USD |
|
Q1 2022 |
Q1 2022 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2022 |
Q3 2022 |